Progress in filovirus vaccine development: evaluating the potential for clinical use
- 9 January 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 10 (1) , 63-77
- https://doi.org/10.1586/erv.10.152
Abstract
(2011). Progress in filovirus vaccine development: evaluating the potential for clinical use. Expert Review of Vaccines: Vol. 10, No. 1, pp. 63-77.Keywords
This publication has 121 references indexed in Scilit:
- Prospects for immunisation against Marburg and Ebola virusesReviews in Medical Virology, 2010
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenicVirology, 2010
- Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challengeVirology, 2008
- Protection against lethal challenge by Ebola virus-like particles produced in insect cellsVirology, 2008
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg virusesVaccine, 2008
- A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animalsVirology, 2008
- Single-Dose, Therapeutic Vaccination of Mice with Vesicular Stomatitis Virus Expressing Human Papillomavirus Type 16 E7 ProteinClinical and Vaccine Immunology, 2008
- Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus InfectionsClinical and Vaccine Immunology, 2008
- Generation of biologically contained Ebola virusesProceedings of the National Academy of Sciences, 2008
- Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primatesVirology, 2006